ASCO 2022 Conference Coverage


 

ASCO 2022 Adjuvant Abemaciclib for High-Risk Early Breast Cancer: Factors Increasing the Rate of Treatment Discontinuations in monarchE

397 views
July 26, 2022
Comments 0
Login to view comments. Click here to Login